Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 429.40
-2.10 (-0.49%)
Jun 1, 2026, 3:29 PM IST
Cohance Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 164,274 | 115,325 | 293,004 | 172,366 | 120,256 | 157,436 | |
Market Cap Growth | -60.16% | -60.64% | 69.99% | 43.33% | -23.61% | 24.49% |
Enterprise Value | 166,245 | 117,196 | 287,341 | 165,176 | 117,048 | 156,449 |
Last Close Price | 429.40 | 301.45 | 1151.00 | 677.10 | 472.40 | 608.53 |
PE Ratio | 91.75 | 64.35 | 109.38 | 57.40 | 29.24 | 34.69 |
Forward PE | 60.79 | 39.98 | 63.44 | 44.40 | 26.23 | 30.48 |
PS Ratio | 7.24 | 5.01 | 24.47 | 16.40 | 8.97 | 11.93 |
PB Ratio | 4.07 | 2.86 | 15.92 | 8.40 | 6.93 | 10.31 |
P/TBV Ratio | 6.50 | 4.56 | 29.97 | 8.67 | 7.19 | 10.32 |
P/FCF Ratio | 110.67 | 77.69 | 221.22 | 51.78 | 70.21 | 61.79 |
P/OCF Ratio | 44.60 | 31.31 | 101.68 | 44.80 | 26.30 | 47.71 |
EV/Sales Ratio | 7.33 | 5.09 | 23.99 | 15.71 | 8.73 | 11.85 |
EV/EBITDA Ratio | 38.93 | 25.42 | 70.85 | 40.39 | 20.44 | 27.00 |
EV/EBIT Ratio | 69.37 | 42.81 | 87.58 | 46.61 | 22.25 | 28.89 |
EV/FCF Ratio | 111.99 | 78.95 | 216.94 | 49.62 | 68.34 | 61.40 |
Debt / Equity Ratio | 0.10 | 0.10 | 0.15 | 0.03 | 0.04 | 0.06 |
Debt / EBITDA Ratio | 0.87 | 0.87 | 0.69 | 0.16 | 0.12 | 0.17 |
Debt / FCF Ratio | 2.70 | 2.70 | 2.11 | 0.20 | 0.41 | 0.38 |
Net Debt / Equity Ratio | 0.02 | 0.02 | 0.00 | -0.37 | -0.24 | -0.28 |
Net Debt / EBITDA Ratio | 0.16 | 0.16 | 0.01 | -1.85 | -0.72 | -0.74 |
Net Debt / FCF Ratio | 0.50 | 0.50 | 0.02 | -2.27 | -2.41 | -1.68 |
Asset Turnover | 0.53 | 0.53 | 0.45 | 0.50 | 0.71 | 0.80 |
Inventory Turnover | 1.80 | 1.80 | 1.85 | 1.32 | 1.87 | 2.24 |
Quick Ratio | 1.56 | 1.56 | 1.78 | 8.61 | 4.17 | 3.85 |
Current Ratio | 2.83 | 2.83 | 2.43 | 10.68 | 6.37 | 5.36 |
Return on Equity (ROE) | 5.11% | 5.11% | 13.61% | 15.86% | 25.21% | 33.52% |
Return on Assets (ROA) | 3.91% | 3.91% | 7.76% | 10.50% | 17.33% | 20.49% |
Return on Invested Capital (ROIC) | 4.91% | 6.67% | 16.10% | 20.05% | 31.95% | 32.95% |
Return on Capital Employed (ROCE) | 5.40% | 5.40% | 12.30% | 16.60% | 29.10% | 33.40% |
Earnings Yield | 1.09% | 1.55% | 0.91% | 1.74% | 3.42% | 2.88% |
FCF Yield | 0.90% | 1.29% | 0.45% | 1.93% | 1.42% | 1.62% |
Dividend Yield | - | - | - | - | 0.64% | 0.33% |
Payout Ratio | - | - | - | - | 49.52% | 22.44% |
Buyback Yield / Dilution | 0.36% | -49.70% | -0.49% | - | 0.00% | 0.00% |
Total Shareholder Return | 0.36% | -49.70% | -0.49% | - | 0.64% | 0.33% |